Product Program year 2020 Source: CMS Open Payments

(820) Cholbam

Drug Hepatology

NDC 45043-001-02

Open in the dashboard

General payments

$214,453

6,691 payments

Research payments

$190,415

87 payments

Through program year 2020, $214,453 in general payments and $190,415 in research payments were reported against (820) Cholbam (Hepatology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $134,455 2,695
2020 Research $141,973 63
2019 General $79,998 3,996
2019 Research $48,442 24

Breakdown

Who paid General payments · program years 2019–2020
  1. Retrophin, Inc. $214,453 6,691 payments
Top recipients General payments · program year 2020
  1. Childrens Hospital Medical Center Teaching hospital · OH $66,000 49% · 1 payment
  2. James Heubi Pediatric Gastroenterology · Cincinnati, OH $11,588 9% · 22 payments
  3. Janaina Anderson Pediatric Gastroenterology · Charleston, SC $9,150 7% · 15 payments
  4. Ryan Himes Pediatric Gastroenterology · New Orleans, LA $8,705 6% · 21 payments
  5. Charina Ramirez Pediatric Gastroenterology · Dallas, TX $7,500 6% · 18 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Pediatric Gastroenterology Pediatrics $43,210 63% · 178 practitioners
  2. Medical Biochemical Genetics Medical Genetics $7,317 11% · 2 practitioners
  3. Pediatrics $6,972 10% · 51 practitioners
  4. Clinical Genetics (M.D.) Medical Genetics $6,542 10% · 53 practitioners
  5. Neurology with Special Qualifications in Child Neurology Psychiatry & Neurology $1,183 2% · 86 practitioners

The top 5 of 51 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Ohio $77,610 58% · 7 recipients
  2. California $10,080 7% · 243 recipients
  3. South Carolina $9,494 7% · 38 recipients
  4. Louisiana $8,947 7% · 11 recipients
  5. Texas $7,673 6% · 24 recipients

The top 5 of 42 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

6,691 general · 87 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record